Glutathione in metastases: From mechanisms to clinical applications

Abstract

Metastatic spread, not primary tumors, is the leading cause of cancer death. Glutathione (γ-glutamyl-cysteinyl-glycine, GSH) is particularly relevant in cancer cells as it is involved in regulating carcinogenic mechanisms, growth and dissemination, and multidrug and radiation resistance. Upon interaction of metastatic cells with the vascular endothelium, a high percentage of metastatic cells with high GSH levels survive the combined nitrosative and oxidative stresses elicited by the vascular endothelium. GSH release from different organs, mainly the liver, and its interorgan transport through the blood circulation to metastatic foci, promote their growth. This review focuses on the relationship among GSH and different key mechanisms that facilitate metastatic cell survival and growth, i.e. adaptive responses to stress, cell death evasion and utilization of physiological neuroendocrine mechanisms. Different strategies that are aimed at sensitizing metastases to cancer therapy by depleting metastatic cell GSH are analyzed.

• Glutathione
• cancer
• metastases
• stress
• neuroendocrine regulation
• oncotherapy

Declaration of interest

The authors declare that there are no conflicts of interest. This research was supported by grants from the MICINN (Ministerio de Ciencia e Innovación) (SAF2009–07729, PT-010000–2010-021) and MINECO (Ministerio de Economía y Competitividad) (SAF2012–31565), Spain.